Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-059954
Filing Date
2013-11-08
Accepted
2013-11-08 15:28:33
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v358431_10q.htm 10-Q 2020380
2 EXHIBIT 31.1 v358431_ex31-1.htm EX-31.1 11084
3 EXHIBIT 31.2 v358431_ex31-2.htm EX-31.2 11261
4 EXHIBIT 32.1 v358431_ex32-1.htm EX-32.1 11560
5 EXHIBIT 32.2 v358431_ex32-2.htm EX-32.2 11776
  Complete submission text file 0001144204-13-059954.txt   6053549

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gnsz-20130930.xml EX-101.INS 654050
7 XBRL TAXONOMY EXTENSION SCHEMA gnsz-20130930.xsd EX-101.SCH 48057
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnsz-20130930_cal.xml EX-101.CAL 27938
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnsz-20130930_def.xml EX-101.DEF 189992
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnsz-20130930_lab.xml EX-101.LAB 294799
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnsz-20130930_pre.xml EX-101.PRE 235526
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
GENSPERA INC (Filer) CIK: 0001421204 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-153829 | Film No.: 131204428
SIC: 2834 Pharmaceutical Preparations